• Study on Long-Term Safety of ZYN002 Gel for Children, Adolescents, and Young Adults with Fragile X Syndrome

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Ireland

  • Study of Zolbetuximab Alone and with Drug Combination for Patients with Advanced Stomach or Gastroesophageal Junction Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy

  • Study on the Safety and Effectiveness of Apraglutide for Patients with Steroid-Resistant Gastrointestinal Acute Graft Versus Host Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Study on the Safety and Effectiveness of Amivantamab and Capmatinib for Patients with Unresectable Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain

  • Study on Latent Autoimmune Diabetes in Adults (LADA) Patients: Evaluating Diabetes Status 3 Years After Treatment with Glutamate Decarboxylase 2

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Norway Sweden

  • Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Germany Spain

  • Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Italy The Netherlands Spain

  • Study on the Effects of GV1001 for Patients with Mild to Moderate Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Finland France Italy The Netherlands Poland Portugal +1

powered by